These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 4922228)

  • 21. [Clinical trial of the therapeutic effect of Amantadine-HCL in Parkinson's Disease].
    Hacohen H; Gurtner B
    Schweiz Med Wochenschr; 1972 Apr; 102(16):583-6. PubMed ID: 5019377
    [No Abstract]   [Full Text] [Related]  

  • 22. Clinical and electromyographic examinations on the effect of hydrochloride (Viregyt-K) in the treatment of Parkinson's disease.
    Schubert U; Fischer GJ; Glass J
    Ther Hung; 1977; 25(2):55-63. PubMed ID: 898119
    [No Abstract]   [Full Text] [Related]  

  • 23. [Amantadine therapy in Parkinsonism].
    Forssman B; Kihlstrand S; Larsson LE
    Lakartidningen; 1972 Mar; 69():55-9. PubMed ID: 4577428
    [No Abstract]   [Full Text] [Related]  

  • 24. [Results of treatment with amantadine hydrochloride in Parkinson's syndrome using psychological test study methods. (Preliminary report)].
    Gerstenbrand F; Grünberger J; Oberhummer I
    Wien Med Wochenschr; 1971 May; 121(19):390-7. PubMed ID: 5559920
    [No Abstract]   [Full Text] [Related]  

  • 25. [Results of treatment with amantadine hydrochloride in Parkinson's syndrome using psychological test study methods. (Preliminary report)].
    Gerstenbrand F; Grünberger J; Oberhummer I
    HNO; 1970 Nov; 18(11):390-7. PubMed ID: 5512006
    [No Abstract]   [Full Text] [Related]  

  • 26. [Experimental and clinical data on the mechanism of action of amantadine and on its effectiveness in Parkinson's disease].
    Beani L; Bianchi C; Gomirato G; Perfetti C; Cartei M
    Minerva Med; 1971 Oct; 62(82):3948-51. PubMed ID: 5125048
    [No Abstract]   [Full Text] [Related]  

  • 27. [Drug therapy of Parkinson's disease with amantadine and levodopa].
    Fieschi C; Nardini M; Casacchia M; Reitano M; Tedone ME; Ferrari P; Robotti E
    Sist Nerv; 1970; 22(2):126-43. PubMed ID: 5504552
    [No Abstract]   [Full Text] [Related]  

  • 28. [The therapeutic effectiveness of amantadine (midantan) in parkinsonism syndromes].
    Kiseleva AM; Zlydnikov DM; Mazhinskaia VP; Lebedeva VK; Zakharova NG
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(4):530-4. PubMed ID: 4705408
    [No Abstract]   [Full Text] [Related]  

  • 29. [Amantadine and dexetimide in the treatment of parkinsonism].
    Hakkarainen H; Viukari M
    Duodecim; 1973 Jul; 89(21):1437-41. PubMed ID: 4586970
    [No Abstract]   [Full Text] [Related]  

  • 30. [Effects of intravenous administration of memantine in parkinsonian patients (author's transl)].
    Fischer PA; Jacobi P; Schneider E; Schönberger B
    Arzneimittelforschung; 1977 Jul; 27(7):1487-9. PubMed ID: 332193
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Efficacy of amantadine sulfate as a infusion solution in the treatment of parkinsonian syndrome].
    Muschard F; Völler GW
    Med Welt; 1973 Feb; 24(5):183-4. PubMed ID: 4617092
    [No Abstract]   [Full Text] [Related]  

  • 32. Combined treatment in Parkinson's disease.
    Wheatley D
    Practitioner; 1983 Mar; 227(1377):446-7. PubMed ID: 6889232
    [No Abstract]   [Full Text] [Related]  

  • 33. [Therapeutic experiences with amantadine sulfate as a monotherapeutic drug in patients with Parkinsonism].
    Völler GW; Deze J
    Z Allgemeinmed; 1973 May; 49(14):664-70. PubMed ID: 4585272
    [No Abstract]   [Full Text] [Related]  

  • 34. [Adamantylamine sulfate--a drug for treatment of Parkinson's disease with a new working principle].
    Fünfgeld EW
    Med Klin; 1970 Sep; 65(39):1703-6. PubMed ID: 5474341
    [No Abstract]   [Full Text] [Related]  

  • 35. Plasma amantadine concentrations in patients with Parkinson's disease.
    Nishikawa N; Nagai M; Moritoyo T; Yabe H; Nomoto M
    Parkinsonism Relat Disord; 2009 Jun; 15(5):351-3. PubMed ID: 18823813
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Amantadine in Parkinsonism. An extended prospective trial.
    Rao NS; Pearce J
    Practitioner; 1971 Feb; 206(232):241-5. PubMed ID: 4928964
    [No Abstract]   [Full Text] [Related]  

  • 37. Amantadine treatment of Parkinson's disease.
    Boman K; Porras J
    Acta Neurol Scand; 1970; 46(S43):225-6. PubMed ID: 4917686
    [No Abstract]   [Full Text] [Related]  

  • 38. [The additive effect of amantadine hydrochloride (Symmetrel) on parkinsonian patients receiving levodopa treatment (author's transl)].
    Shiozawa R; Kase M; Kuroiwa Y; Narabayashi H; Nishitani Y; Ohmoto T; Toyokura Y; Uono K
    No To Shinkei; 1981 Mar; 33(3):301-9. PubMed ID: 7018522
    [No Abstract]   [Full Text] [Related]  

  • 39. Controlled trial of amantadine hydrochloride in Parkinson's disease.
    Parkes JD; Calver DM; Zilkha KJ; Knill-Jones RP
    Lancet; 1970 Feb; 1(7641):259-62. PubMed ID: 4189290
    [No Abstract]   [Full Text] [Related]  

  • 40. The effect of adding amantadine to optimum L-dopa dosage in Parkinson's syndrome.
    Fehling C
    Acta Neurol Scand; 1973; 49(2):245-51. PubMed ID: 4577929
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.